A Study to Compare the Bioavailability of Intravenously Infused Risankizumab Manufactured by Two Different Processes in Healthy Adults
Clinical trial NCT06054425 · COMPLETED
Trial details
- NCT number
- NCT06054425
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-20
- Primary completion
- 2024-05-06
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.